Authors: LOUWERENS M SCHORNAGEL J DEMULDER PHM DEWIT R

Citation: M. Louwerens et al., A DOSE-FINDING STUDY OF PACLITAXEL (TAXOL) ADDED TO FIXED DOSES OF BLEOMYCIN, ETOPOSIDE, CISPLATIN (BEP) IN PATIENTS WITH ADVERSE PROGNOSISGERM-CELL CANCER OR CARCINOMA OF UNKNOWN PRIMARY (CUP), Annals of oncology, 9, 1998, pp. 366-366

Authors: VERWEIJ J DEMULDER PHM DEGRAEFF A VERMORKEN JB WILDIERS J KERGER J SCHORNAGEL J COGNETTI F KIRKPATRICK A SAHMOUD T LEFEBVRE JL

Citation: J. Verweij et al., PHASE-II STUDY ON MITOXANTRONE IN ADENOID CYSTIC CARCINOMAS OF THE HEAD AND NECK, Annals of oncology, 7(8), 1996, pp. 867-869

Authors: ZALCBERG JR CUNNINGHAM D VANCUTSEM E FRANCOIS E SCHORNAGEL J ADENIS A GREEN M IVESON A AZAB M SEYMOUR I

Citation: Jr. Zalcberg et al., ZD1694 - A NOVEL THYMIDYLATE SYNTHASE INHIBITOR WITH SUBSTANTIAL ACTIVITY IN THE TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 14(3), 1996, pp. 716-721

Authors: WANG X JANSEN G FAN JG KOHLER WJ ROSS JF SCHORNAGEL J RATNAM M

Citation: X. Wang et al., VARIANT GPI STRUCTURE IN RELATION TO MEMBRANE-ASSOCIATED FUNCTIONS OFA MURINE FOLATE RECEPTOR, Biochemistry, 35(50), 1996, pp. 16305-16312

Authors: LOS G TUYT L VANVUGT M SCHORNAGEL J PINEDO HM

Citation: G. Los et al., COMBINATION TREATMENT OF CISPLATIN AND CARBOPLATIN IN CANCERS RESTRICTED TO THE PERITONEAL-CAVITY IN THE RAT, Cancer chemotherapy and pharmacology, 32(6), 1993, pp. 425-433